Currently out of the existing stock ratings of Carter Gould, 99 are a BUY (60%), 44 are a HOLD (26.67%), 22 are a SELL (13.33%).

Carter Gould

Work Performance Price Targets & Ratings Chart

Analyst Carter Gould works at BARCLAYS with a stock forecast success ratio of 68.55% fulfilled within 203.38 days on average. Previously, Carter Gould worked at UBS.

Carter Gould’s has documented 366 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GILD, Gilead Sciences at 12-Feb-2024.

Wall Street Analyst Carter Gould

Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.

Average potential price target upside

ABBV AbbVie ALLK Allakos AMGN Amgen APLT Applied Therapeutics BIIB Biogen BMY Bristol-Myers Squibb Company CYTK Cytokinetics GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany NBIX Neurocrine Biosciences PFE Pfizer REGN Regeneron Pharmaceuticals TVTX Travere Therapeutics XLRN Acceleron Pharma GOSS Gossamer Bio RETA Reata Pharmaceuticals ALEC Alector CELG Celgene MTEM Molecular Templates VOR Vor Biopharma ACLX Arcellx ESPR Esperion Therapeutics INCY yte VRTX Vertex Pharmaceuticals SKIL Skillsoft Corp.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

189

$13.86 (7.91%)

181

17 days ago

9/13 (69.23%)

$20.33 (12.05%)

256

Buy

185

$9.86 (5.63%)

175

17 days ago

11/12 (91.67%)

$16.33 (9.68%)

140

Buy

195

$19.86 (11.34%)

180

17 days ago

7/10 (70%)

$26.33 (15.61%)

402

Hold

156

$-19.14 (-10.93%)

167

2 months 5 days ago

2/2 (100%)

$2.58 (1.68%)

109

Buy

173

$-2.14 (-1.22%)

122

2 months 12 days ago

1/3 (33.33%)

$21.76 (14.39%)

58

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Carter Gould is most bullish on?

Potential upside of $55.11 has been obtained for REGN (REGENERON PHARMACEUTICALS)

Which stock is Carter Gould is most reserved on?

Potential downside of -$89.64 has been obtained for LLY (ELI LILLY AND COMPANY)

What Year was the first public recommendation made by Carter Gould?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?